We are live on ! Find out more
BCM

Beryl Capital Management Portfolio holdings

AUM $110M
1-Year Est. Return 317.92%
This Fund
S&P 500
This Quarter Est. Return
+39.2%
1 Year Est. Return
+317.92%
3 Year Est. Return
+5,124.04%
5 Year Est. Return
+10,319.28%
10 Year Est. Return
AUM
$620M
AUM Growth
+$233M
Cap. Flow
+$153M
Cap. Flow %
24.64%
Top 10 Hldgs %
73.77%
Holding
70
New
41
Increased
5
Reduced
Closed
22

Sector Composition

Rank Sector Weight
1 Healthcare 22.13%
2 Industrials 8.99%
3 Technology 7.25%
4 Communication Services 6.38%
5 Energy 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRCI
26
DELISTED
SRC Energy Inc
SRCI
$1.68M 0.27%
+406,869
New +$1.54M
NIHD
27
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$1.6M 0.26%
+738,428
New +$1.43M
PBBI
28
DELISTED
PB Bancorp, Inc. Common Stock
PBBI
$1.57M 0.25%
+103,924
New +$1.48M
WLH
29
DELISTED
WILLIAM LYON HOMES
WLH
$1.57M 0.25%
+78,772
New +$1.61M
MFSF
30
DELISTED
MutualFirst Financial Inc
MFSF
$1.57M 0.25%
+39,639
New +$1.46M
TRCB
31
DELISTED
Two River Bancorp
TRCB
$1.39M 0.22%
+62,162
New +$1.32M
MSBF
32
DELISTED
MSB Financial Corp.
MSBF
$1.39M 0.22%
+76,936
New +$1.23M
FSBC
33
DELISTED
FSB Bancorp, Inc. Common Stock
FSBC
$1.27M 0.2%
+73,073
New +$1.24M
ENFC
34
DELISTED
Entegra Financial Corp.
ENFC
$1.18M 0.19%
+39,166
New +$1.18M
CRNC icon
35
Cerence
CRNC
$405M
$892K 0.14%
+39,398
New +$646K
RPLA
36
DELISTED
Replay Acquisition Corp. Ordinary Shares
RPLA
$865K 0.14%
86,239
CART
37
DELISTED
Carolina Trust BancShares
CART
$847K 0.14%
+64,927
New +$758K
BKJ
38
DELISTED
Bancorp of New Jersey, Inc.
BKJ
$559K 0.09%
31,235
+200
+0.6% +$3.66K
CRCM
39
DELISTED
CARE.COM, INC.
CRCM
$534K 0.09%
+35,497
New +$426K
SORL
40
DELISTED
SORL Auto Parts, Inc.
SORL
$428K 0.07%
+96,341
New +$352K
AYR
41
DELISTED
Aircastle Ltd
AYR
$389K 0.06%
+12,165
New +$351K
SPCE.WS
42
DELISTED
Virgin Galactic Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stoc
SPCE.WS
$384K 0.06%
+114,650
New +$275K
CDOR
43
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
$269K 0.04%
+24,366
New +$269K
SGB
44
DELISTED
Southwest Georgia Financial Corporation
SGB
$221K 0.04%
+6,295
New +$149K
BROGW
45
DELISTED
Brooge Holdings Limited Warrant expiring 12/20/2024
BROGW
$39K 0.01%
+53,384
New +$28K
RPLA.WS
46
DELISTED
Replay Acquisition Corp. Warrants
RPLA.WS
$36K 0.01%
43,119
BRMK.WS
47
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$23K ﹤0.01%
+59,232
New +$18.1K
FIT
48
CALL
DELISTED
Fitbit, Inc. Class A common stock
FIT
$1K ﹤0.01%
+24,250
New +$142K
BN icon
49
Brookfield
BN
$106B
-82,011
Closed -$1.55M
ZAYO
50
DELISTED
Zayo Group Holdings, Inc.
ZAYO
-41,002
Closed -$1.39M

Similar funds

Beryl Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Beryl Capital Management held 70 positions worth $620M, up 60% from $388M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Beryl Capital Management deployed $153M of net new capital in Q4 2019, opening 41 new positions and adding to 5 existing holdings. Its largest new stake was Tiffany & Co.: 559,900 shares worth $74.8M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 37% a quarter earlier, followed by Industrials and Technology.

On the sell side, the most notable exit was Celgene Corp, an estimated $91.5M sold.

  • Beryl Capital Management's largest Q4 2019 buy was Tiffany & Co.: 559,900 shares worth $74.8M.
  • Beryl Capital Management added most to Allergan plc in Q4 2019, an estimated $67.8M increase.
  • Beryl Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $91.5M.
  • Beryl Capital Management's ten largest holdings make up 74% of its $620M portfolio in Q4 2019.
  • Beryl Capital Management opened 41 new positions and closed 22 in Q4 2019.
  • Beryl Capital Management's portfolio value rose 60% quarter-over-quarter to $620M.

Based on Beryl Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.